(Q35779345)

English

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

scientific article published on 9 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling (English)

1 reference

Europe PubMed Central

10 August 2017

ductal carcinoma

1 reference

based on heuristic

inferred from title

Charles M. Perou

12

1 reference

Europe PubMed Central

10 August 2017

13

object named as

David Haussler

0 references

Vilde D Haakensen

9

0 references

Charles J Vaske

2

0 references

Fredrik Wärnberg

8

0 references

4

0 references

Åslaug Helland

10

0 references

Anne-Lise Børresen-Dale

15

object named as

Anne-Lise Børresen-Dale

1 reference

Europe PubMed Central

10 August 2017

Therese Sørlie

7

object named as

Therese Sørlie

1 reference

Europe PubMed Central

10 August 2017

Olga Troyanskaya

14

object named as

Olga G Troyanskaya

1 reference

Europe PubMed Central

10 August 2017

Vessela Kristensen

1

object named as

Vessela N Kristensen

1 reference

Europe PubMed Central

10 August 2017

11

object named as

Bjørn Naume

1 reference

Europe PubMed Central

10 August 2017

Silje H. Nordgard

5

object named as

Silje H Nordgard

1 reference

Europe PubMed Central

10 August 2017

Josie Ursini-Siegel

3

object named as

Josie Ursini-Siegel

1 reference

Europe PubMed Central

10 August 2017

Ravi Sachidanandam

6

object named as

Ravi Sachidanandam

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

9 September 2011

1 reference

Europe PubMed Central

10 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

10 August 2017

109

1 reference

Europe PubMed Central

10 August 2017

8

1 reference

Europe PubMed Central

10 August 2017

2802-2807

1 reference

Europe PubMed Central

10 August 2017

Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Induction of human epithelial stem/progenitor expansion by FOXM1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

New perspectives: role of sunitinib in breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Allele-specific copy number analysis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Immunity, Inflammation, and Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Complementary actions of inhibitors of angiopoietin-2 and VEGF on tumor angiogenesis and growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Upregulation of FOXM1 induces genomic instability in human epidermal keratinocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Secondary replicative function of CD8+ T cells that had developed an effector phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

PID: the Pathway Interaction Database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Role of ErbB4 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Stromal gene expression predicts clinical outcome in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Creating immune privilege: active local suppression that benefits friends, but protects foes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Interferons, immunity and cancer immunoediting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

The inflammatory tumor microenvironment and its impact on cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Paradoxical roles of the immune system during cancer development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

Molecular portraits of human breast tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3286992

27 July 2018

De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Tumor-associated macrophages press the angiogenic switch in breast cancer.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

FoxM1 is required for execution of the mitotic programme and chromosome stability

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.1108781108

21 January 2018

Cancer: Macrophages limit chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21908711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/21908711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21908711

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.1108781108

1 reference

Europe PubMed Central

10 August 2017

2012PNAS..109.2802K

0 references

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35779345&oldid=1858525466"